Hello

Your subscription is almost coming to an end. Don’t miss out on the great content on Nation.Africa

Ready to continue your informative journey with us?

Hello

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and in-depth features.

Reclaim your full access. Click below to renew.

Only 29% hospitalised Covid patients fully well one year on - study

Health workers attend to a Covid-19 patient in an ICU at Mulago National Referral Hospital early 2021. PHOTO/ PROMISE TWINAMUKYE

What you need to know:

  • The most common long-Covid symptoms were fatigue, muscle pain, poor sleep, slowing down physically and breathlessness.

Not even one in four people have completely recovered from Covid a full year after being hospitalised with the disease, a UK study indicated Sunday, warning that long Covid could become a common condition.

The study involving more than 2,300 people also found that women were 33 percent less likely to fully recover than men.

It also found that obese people were half as likely to fully recover, while those who needed mechanical ventilation were 58 percent less likely.

The study looked at the health of people who were discharged from 39 British hospitals with Covid between March 2020 and April 2021, then assessed the recovery of 807 of them five months and one year later.

Just 26 percent reported a full recovery after five months, and that number rose only slightly to 28.9 percent after a year, according to the study published in the Lancet Respiratory Medicine journal.

"The limited recovery from five months to one year after hospitalisation in our study across symptoms, mental health, exercise capacity, organ impairment and quality-of-life is striking," said study co-leader Rachel Evans of the National Institute for Health and Care Research.

The most common long-Covid symptoms were fatigue, muscle pain, poor sleep, slowing down physically and breathlessness.

"Without effective treatments, long Covid could become a highly prevalent new long-term condition," said study co-lead Christopher Brightling of the University of Leicester.

The study, which will be presented at the European Congress of Clinical Microbiology and Infectious Diseases, is ongoing and will continue to monitor the patients' health.